Cargando…
MicroRNA-325-3p contributes to colorectal carcinoma by targeting cytokeratin 18
Colorectal carcinoma (CRC) is one of the most common malignant tumors. The present study aimed to investigate a non-invasive molecular marker that can evaluate the diagnosis and potential molecular mechanism of CRC. Microarray assays and reverse transcription-quantitative PCR analysis demonstrated t...
Autores principales: | Song, Chuanfang, Wang, Xiujie, Zhao, Xinxin, Ai, Jiang, Qi, Yixuan, Chen, Aidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882876/ https://www.ncbi.nlm.nih.gov/pubmed/33664812 http://dx.doi.org/10.3892/ol.2021.12509 |
Ejemplares similares
-
The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2015) -
MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder
Cancer
por: Lin, Tao, et al.
Publicado: (2018) -
Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2018) -
Retraction Note: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2018) -
Cytokeratin 18 Is Not Required for Morphogenesis of Developing Prostates but Contributes to Adult Prostate Regeneration
por: Zhang, Chenlu, et al.
Publicado: (2013)